List of Tables
Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Surgery
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Key Players of Other
Table 6. Global Kidney Cancer Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Kidney Cancer Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Kidney Cancer Market Share by Region (2019-2024)
Table 10. Global Kidney Cancer Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Kidney Cancer Market Share by Region (2025-2030)
Table 12. Kidney Cancer Market Trends
Table 13. Kidney Cancer Market Drivers
Table 14. Kidney Cancer Market Challenges
Table 15. Kidney Cancer Market Restraints
Table 16. Global Kidney Cancer Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Kidney Cancer Market Share by Players (2019-2024)
Table 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)
Table 19. Ranking of Global Top Kidney Cancer Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Kidney Cancer, Headquarters and Area Served
Table 22. Global Key Players of Kidney Cancer, Product and Application
Table 23. Global Key Players of Kidney Cancer, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Kidney Cancer Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Kidney Cancer Revenue Market Share by Type (2019-2024)
Table 27. Global Kidney Cancer Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Kidney Cancer Revenue Market Share by Type (2025-2030)
Table 29. Global Kidney Cancer Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Kidney Cancer Revenue Market Share by Application (2019-2024)
Table 31. Global Kidney Cancer Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Kidney Cancer Revenue Market Share by Application (2025-2030)
Table 33. North America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Kidney Cancer Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Kidney Cancer Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Kidney Cancer Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Kidney Cancer Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Kidney Cancer Market Size by Country (2025-2030) & (US$ Million)
Table 48. Merck Company Details
Table 49. Merck Business Overview
Table 50. Merck Kidney Cancer Product
Table 51. Merck Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Novartis Company Details
Table 54. Novartis Business Overview
Table 55. Novartis Kidney Cancer Product
Table 56. Novartis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Bristol-Myers Squibb Company Details
Table 59. Bristol-Myers Squibb Business Overview
Table 60. Bristol-Myers Squibb Kidney Cancer Product
Table 61. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 62. Bristol-Myers Squibb Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Kidney Cancer Product
Table 66. Pfizer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Roche Company Details
Table 69. Roche Business Overview
Table 70. Roche Kidney Cancer Product
Table 71. Roche Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 72. Roche Recent Development
Table 73. Amgen Company Details
Table 74. Amgen Business Overview
Table 75. Amgen Kidney Cancer Product
Table 76. Amgen Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 77. Amgen Recent Development
Table 78. Aveo Pharmaceuticals Company Details
Table 79. Aveo Pharmaceuticals Business Overview
Table 80. Aveo Pharmaceuticals Kidney Cancer Product
Table 81. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 82. Aveo Pharmaceuticals Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Kidney Cancer Product
Table 86. Bayer Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Exelixis Company Details
Table 89. Exelixis Business Overview
Table 90. Exelixis Kidney Cancer Product
Table 91. Exelixis Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 92. Exelixis Recent Development
Table 93. Eisai Company Details
Table 94. Eisai Business Overview
Table 95. Eisai Kidney Cancer Product
Table 96. Eisai Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 97. Eisai Recent Development
Table 98. Hikma Pharmaceuticals Company Details
Table 99. Hikma Pharmaceuticals Business Overview
Table 100. Hikma Pharmaceuticals Kidney Cancer Product
Table 101. Hikma Pharmaceuticals Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 102. Hikma Pharmaceuticals Recent Development
Table 103. Sun Pharmaceutical Company Details
Table 104. Sun Pharmaceutical Business Overview
Table 105. Sun Pharmaceutical Kidney Cancer Product
Table 106. Sun Pharmaceutical Revenue in Kidney Cancer Business (2019-2024) & (US$ Million)
Table 107. Sun Pharmaceutical Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Kidney Cancer Picture
Figure 2. Global Kidney Cancer Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Kidney Cancer Market Share by Type: 2023 VS 2030
Figure 4. Surgery Features
Figure 5. Immunotherapy Features
Figure 6. Targeted Therapy Features
Figure 7. Other Features
Figure 8. Global Kidney Cancer Market Size by Application (2024-2030) & (US$ Million)
Figure 9. Global Kidney Cancer Market Share by Application: 2023 VS 2030
Figure 10. Renal Cell Carcinoma Case Studies
Figure 11. Renal Pelvis Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Kidney Cancer Report Years Considered
Figure 14. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Kidney Cancer Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Kidney Cancer Market Share by Region: 2023 VS 2030
Figure 17. Global Kidney Cancer Market Share by Players in 2023
Figure 18. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2023
Figure 20. North America Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Kidney Cancer Market Share by Country (2019-2030)
Figure 22. United States Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Kidney Cancer Market Share by Country (2019-2030)
Figure 26. Germany Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Kidney Cancer Market Share by Region (2019-2030)
Figure 34. China Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Kidney Cancer Market Share by Country (2019-2030)
Figure 42. Mexico Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Kidney Cancer Market Share by Country (2019-2030)
Figure 46. Turkey Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. UAE Kidney Cancer Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Merck Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 50. Novartis Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 52. Pfizer Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 53. Roche Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 54. Amgen Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 55. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 56. Bayer Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 57. Exelixis Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 58. Eisai Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 60. Sun Pharmaceutical Revenue Growth Rate in Kidney Cancer Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed